Bryan K. Yamamoto - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Neuroscience Biology

87 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Natarajan R, Mitchell CM, Harless N, Yamamoto BK. Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration. Scientific Reports. 8: 10558. PMID 30002494 DOI: 10.1038/S41598-018-28970-1  0.36
2017 Natarajan R, Forrester L, Chiaia N, Yamamoto BK. Chronic Stress-induced Behavioral Changes Associated with Subregion Selective Serotonin Cell Death in the Dorsal Raphe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28546314 DOI: 10.1523/Jneurosci.3781-16.2017  0.36
2017 Natarajan R, Northrop N, Yamamoto B. Fluorescein Isothiocyanate (FITC)-Dextran Extravasation as a Measure of Blood-Brain Barrier Permeability. Current Protocols in Neuroscience. 79: 9.58.1-9.58.15. PMID 28398646 DOI: 10.1002/Cpns.25  0.36
2016 Huff CL, Morano RL, Herman JP, Yamamoto BK, Gudelsky GA. MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate. Neurotoxicology. PMID 27773601 DOI: 10.1016/J.Neuro.2016.10.011  0.4
2016 Northrop NA, Halpin LE, Yamamoto BK. Peripheral ammonia and blood brain barrier structure and function after methamphetamine. Neuropharmacology. 107: 18-26. PMID 26972828 DOI: 10.1016/J.Neuropharm.2016.03.018  1
2015 Collins SA, Huff C, Chiaia N, Gudelsky GA, Yamamoto BK. MDMA Increases Excitability in the Dentate Gyrus: Role of 5HT2A Receptor Induced PGE2 Signaling. Journal of Neurochemistry. PMID 26670377 DOI: 10.1111/Jnc.13493  0.36
2015 Natarajan R, Northrop NA, Yamamoto BK. Protracted effects of chronic stress on serotonin-dependent thermoregulation. Stress (Amsterdam, Netherlands). 1-9. PMID 26414686 DOI: 10.3109/10253890.2015.1087502  0.36
2015 Collins SA, Gudelsky GA, Yamamoto BK. MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors. European Journal of Pharmacology. 761: 95-100. PMID 25936514 DOI: 10.1016/J.Ejphar.2015.04.035  0.92
2015 Northrop NA, Yamamoto BK. Methamphetamine effects on blood-brain barrier structure and function. Frontiers in Neuroscience. 9: 69. PMID 25788874 DOI: 10.3389/Fnins.2015.00069  1
2014 Poddar NK, Zano S, Natarajan R, Yamamoto B, Viola RE. Enhanced brain distribution of modified aspartoacylase. Molecular Genetics and Metabolism. 113: 219-24. PMID 25066302 DOI: 10.1016/J.Ymgme.2014.07.002  0.92
2014 Weber GF, Johnson BN, Yamamoto BK, Gudelsky GA. Effects of stress and MDMA on hippocampal gene expression. Biomed Research International. 2014: 141396. PMID 24511526 DOI: 10.1155/2014/141396  0.92
2014 Halpin LE, Northrop NA, Yamamoto BK. Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1031-8. PMID 24165886 DOI: 10.1038/Npp.2013.306  1
2014 Halpin LE, Collins SA, Yamamoto BK. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sciences. 97: 37-44. PMID 23892199 DOI: 10.1016/J.Lfs.2013.07.014  0.72
2013 Halpin LE, Gunning WT, Yamamoto BK. Methamphetamine causes acute hyperthermia-dependent liver damage. Pharmacology Research & Perspectives. 1: e00008. PMID 25505562 DOI: 10.1002/Prp2.8  0.72
2013 Northrop NA, Yamamoto BK. Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine. Neuropharmacology. 72: 96-105. PMID 23643743 DOI: 10.1016/J.Neuropharm.2013.04.040  1
2013 Huff C, Bhide N, Schroering A, Yamamoto BK, Gudelsky GA. Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake. Brain Research Bulletin. 91: 52-7. PMID 23318273 DOI: 10.1016/J.Brainresbull.2013.01.003  0.92
2013 Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65. PMID 23179355 DOI: 10.1007/S11481-012-9420-X  0.92
2012 Peritore CS, Ho A, Yamamoto BK, Schaus SE. Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells. Neuroreport. 23: 989-94. PMID 23114623 DOI: 10.1097/Wnr.0B013E32835A4Ea4  0.92
2012 Halpin LE, Yamamoto BK. Peripheral ammonia as a mediator of methamphetamine neurotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13155-63. PMID 22993432 DOI: 10.1523/Jneurosci.2530-12.2012  0.72
2012 Northrop NA, Yamamoto BK. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 951-68. PMID 22833424 DOI: 10.1007/S11481-012-9391-Y  1
2011 Natarajan R, Yamamoto BK. The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines. Basal Ganglia. 1: 49-57. PMID 21804952 DOI: 10.1016/J.Baga.2011.05.003  0.92
2011 Moszczynska A, Yamamoto BK. Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. Journal of Neurochemistry. 116: 1005-17. PMID 21166679 DOI: 10.1111/J.1471-4159.2010.07147.X  0.92
2011 Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals. The Journal of Pharmacology and Experimental Therapeutics. 336: 900-7. PMID 21159748 DOI: 10.1124/Jpet.110.177287  0.92
2011 McFadden L, Yamamoto BK, Matuszewich L. Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine. Behavioural Brain Research. 216: 726-30. PMID 20817044 DOI: 10.1016/J.Bbr.2010.08.041  0.92
2011 Northrop NA, Northrup NA, Yamamoto BK. Neuroimmune pharmacology from a neuroscience perspective. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 6: 10-9. PMID 20717737 DOI: 10.1007/S11481-010-9239-2  1
2010 Johnson BN, Yamamoto BK. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. The Journal of Pharmacology and Experimental Therapeutics. 335: 180-9. PMID 20634423 DOI: 10.1124/Jpet.110.171322  0.92
2010 Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Annals of the New York Academy of Sciences. 1187: 101-21. PMID 20201848 DOI: 10.1111/J.1749-6632.2009.05141.X  0.92
2010 Northrop NA, Yamamoto BK. Erratum to: Neuroimmune Pharmacology from a Neuroscience Perspective Journal of Neuroimmune Pharmacology. 6: 171-171. DOI: 10.1007/S11481-010-9244-5  1
2009 Cunningham JI, Raudensky J, Tonkiss J, Yamamoto BK. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behavioral Neuroscience. 123: 1076-84. PMID 19824774 DOI: 10.1037/A0016716  1
2009 Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Research. 1286: 32-41. PMID 19555677 DOI: 10.1016/J.Brainres.2009.06.042  0.92
2009 Johnson BN, Yamamoto BK. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone. Neuroscience. 159: 1233-43. PMID 19409219 DOI: 10.1016/J.Neuroscience.2009.01.067  0.92
2008 Yamamoto BK, Raudensky J. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 203-17. PMID 18709468 DOI: 10.1007/S11481-008-9121-7  1
2008 López Patiño MA, Yu L, Yamamoto BK, Zhdanova IV. Gender differences in zebrafish responses to cocaine withdrawal. Physiology & Behavior. 95: 36-47. PMID 18499199 DOI: 10.1016/J.Physbeh.2008.03.021  0.92
2008 Tata DA, Yamamoto BK. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum. Synapse (New York, N.Y.). 62: 325-36. PMID 18288648 DOI: 10.1002/Syn.20497  0.92
2008 Gudelsky GA, Yamamoto BK. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacology, Biochemistry, and Behavior. 90: 198-207. PMID 18035407 DOI: 10.1016/J.Pbb.2007.10.003  0.92
2007 Tata DA, Raudensky J, Yamamoto BK. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia. The European Journal of Neuroscience. 26: 739-48. PMID 17686046 DOI: 10.1111/J.1460-9568.2007.05688.X  0.92
2007 Eyerman DJ, Yamamoto BK. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. Journal of Neurochemistry. 103: 1219-27. PMID 17683483 DOI: 10.1111/J.1471-4159.2007.04837.X  1
2007 Mark KA, Quinton MS, Russek SJ, Yamamoto BK. Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6823-31. PMID 17581970 DOI: 10.1523/Jneurosci.0013-07.2007  0.92
2007 Hatzipetros T, Raudensky JG, Soghomonian JJ, Yamamoto BK. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5895-902. PMID 17537960 DOI: 10.1523/Jneurosci.5260-06.2007  0.92
2007 Tata DA, Yamamoto BK. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction (Abingdon, England). 102: 49-60. PMID 17493053 DOI: 10.1111/J.1360-0443.2007.01770.X  0.92
2007 Raudensky J, Yamamoto BK. Effects of chronic unpredictable stress on monoamine transporter immunoreactivity and methamphetamine-induced dopamine release in the nucleus accumbens shell. Synapse (New York, N.Y.). 61: 353-5. PMID 17318887 DOI: 10.1002/Syn.20374  1
2007 Raudensky J, Yamamoto BK. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Research. 1135: 129-35. PMID 17198685 DOI: 10.1016/J.Brainres.2006.12.002  1
2007 Amato JL, Bankson MG, Yamamoto BK. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 946-54. PMID 16885935 DOI: 10.1038/Sj.Npp.1301174  0.92
2006 Hatzipetros T, Yamamoto BK. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra. Brain Research. 1076: 60-7. PMID 16680828 DOI: 10.1016/J.Brainres.2006.01.015  1
2006 Breier JM, Bankson MG, Yamamoto BK. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 290-9. PMID 16399699 DOI: 10.1523/Jneurosci.3353-05.2006  0.92
2005 Yamamoto BK, Bankson MG. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Critical Reviews in Neurobiology. 17: 87-117. PMID 16808729 DOI: 10.1615/Critrevneurobiol.V17.I2.30  0.92
2005 Broom SL, Yamamoto BK. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats. Psychopharmacology. 181: 467-76. PMID 15986185 DOI: 10.1007/S00213-005-0007-6  0.92
2005 Darvesh AS, Yamamoto BK, Gudelsky GA. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 312: 694-701. PMID 15456837 DOI: 10.1124/Jpet.104.074849  0.92
2005 Eyerman DJ, Yamamoto BK. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. The Journal of Pharmacology and Experimental Therapeutics. 312: 160-9. PMID 15331654 DOI: 10.1124/Jpet.104.072264  1
2004 Matuszewich L, Yamamoto BK. Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum. Annals of the New York Academy of Sciences. 1032: 312-4. PMID 15677439 DOI: 10.1196/Annals.1314.049  0.92
2004 Mark KA, Soghomonian JJ, Yamamoto BK. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11449-56. PMID 15601951 DOI: 10.1523/Jneurosci.3597-04.2004  0.92
2004 Bankson MG, Yamamoto BK. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. Journal of Neurochemistry. 91: 852-9. PMID 15525339 DOI: 10.1111/J.1471-4159.2004.02763.X  0.92
2004 Soares J, Kliem MA, Betarbet R, Greenamyre JT, Yamamoto B, Wichmann T. Role of external pallidal segment in primate parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism and lesions of the external pallidal segment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6417-26. PMID 15269251 DOI: 10.1523/Jneurosci.0836-04.2004  0.92
2004 Jaskiw GE, Hussain G, Stephans SE, Yamamoto BK, Meltzer HY. Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum. Neuroscience Letters. 362: 35-8. PMID 15147775 DOI: 10.1016/J.Neulet.2004.01.079  0.92
2004 Matuszewich L, Yamamoto BK. Chronic stress augments the long-term and acute effects of methamphetamine. Neuroscience. 124: 637-46. PMID 14980734 DOI: 10.1016/J.Neuroscience.2003.12.007  0.92
2003 Matuszewich L, Yamamoto BK. Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats. Psychopharmacology. 169: 169-75. PMID 12768269 DOI: 10.1007/S00213-003-1498-7  0.92
2003 Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, Silver J, Weeber EJ, Sweatt JD, Deneris ES. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron. 37: 233-47. PMID 12546819 DOI: 10.1016/S0896-6273(02)01167-4  0.92
2003 Haxhiu MA, Kc P, Neziri B, Yamamoto BK, Ferguson DG, Massari VJ. Catecholaminergic microcircuitry controlling the output of airway-related vagal preganglionic neurons. Journal of Applied Physiology (Bethesda, Md. : 1985). 94: 1999-2009. PMID 12514167 DOI: 10.1152/Japplphysiol.01066.2002  0.92
2003 Gudelsky GA, Yamamoto BK. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine. 79: 55-73. PMID 12506690 DOI: 10.1385/1-59259-358-5:55  0.92
2002 Haxhiu MA, Yamamoto BK, Dreshaj IA, Ferguson DG. Activation of the midbrain periaqueductal gray induces airway smooth muscle relaxation. Journal of Applied Physiology (Bethesda, Md. : 1985). 93: 440-9. PMID 12133848 DOI: 10.1152/Japplphysiol.00752.2001  0.92
2002 Matuszewich L, Filon ME, Finn DA, Yamamoto BK. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine. Neuroscience. 110: 41-8. PMID 11882371 DOI: 10.1016/S0306-4522(01)00539-5  0.92
2001 Jaskiw GE, Collins KA, Pehek EA, Yamamoto BK. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 149-56. PMID 11377928 DOI: 10.1016/S0893-133X(01)00220-2  0.92
2001 Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. Journal of Neurochemistry. 77: 647-54. PMID 11299327 DOI: 10.1046/J.1471-4159.2001.00262.X  0.92
2001 Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse (New York, N.Y.). 40: 55-64. PMID 11170222 DOI: 10.1002/1098-2396(200104)40:1<55::Aid-Syn1026>3.0.Co;2-O  0.92
2000 Harold C, Wallace T, Friedman R, Gudelsky G, Yamamoto B. Methamphetamine selectively alters brain glutathione. European Journal of Pharmacology. 400: 99-102. PMID 10913590 DOI: 10.1016/S0014-2999(00)00392-7  0.92
2000 Burrows KB, Gudelsky G, Yamamoto BK. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. European Journal of Pharmacology. 398: 11-8. PMID 10856443 DOI: 10.1016/S0014-2999(00)00264-8  0.92
2000 Haxhiu MA, Yamamoto B, Dreshaj IA, Bedol D, Ferguson DG. Involvement of glutamate in transmission of afferent constrictive inputs from the airways to the nucleus tractus solitarius in ferrets Journal of the Autonomic Nervous System. 80: 22-30. PMID 10742536 DOI: 10.1016/S0165-1838(99)00088-0  0.92
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology. 385: 103-10. PMID 10607865 DOI: 10.1016/S0014-2999(99)00728-1  0.92
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. Journal of Neurochemistry. 72: 2516-22. PMID 10349862 DOI: 10.1046/J.1471-4159.1999.0722516.X  0.92
1999 Matuszewich L, Yamamoto BK. Modulation of GABA release by dopamine in the substantia nigra. Synapse (New York, N.Y.). 32: 29-36. PMID 10188635 DOI: 10.1002/(Sici)1098-2396(199904)32:1<29::Aid-Syn4>3.0.Co;2-2  0.92
1998 Mickley GA, Schaldach MA, Snyder KJ, Balogh SA, Len T, Neimanis K, Goulis P, Hug J, Sauchak K, Remmers-Roeber DR, Walker C, Yamamoto BK. Ketamine blocks a conditioned taste aversion (CTA) in neonatal rats. Physiology & Behavior. 64: 381-90. PMID 9748108 DOI: 10.1016/S0031-9384(98)00097-3  0.92
1998 Stephans SE, Whittingham TS, Douglas AJ, Lust WD, Yamamoto BK. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. Journal of Neurochemistry. 71: 613-21. PMID 9681451 DOI: 10.1046/J.1471-4159.1998.71020613.X  0.92
1996 Stephans S, Yamamoto B. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience. 72: 593-600. PMID 8861054 DOI: 10.1016/0306-4522(95)00587-0  0.92
1995 Stephans SE, Yamamoto BY. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Research. 700: 99-106. PMID 8624733 DOI: 10.1016/0006-8993(95)00938-M  0.92
1994 Stephans SE, Yamamoto BK. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse (New York, N.Y.). 17: 203-9. PMID 7974204 DOI: 10.1002/Syn.890170310  0.92
1994 Pehek EA, Yamamoto BK. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. Journal of Neurochemistry. 63: 2118-24. PMID 7964731 DOI: 10.1046/J.1471-4159.1994.63062118.X  0.92
1994 Gudelsky GA, Yamamoto BK, Nash JF. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. European Journal of Pharmacology. 264: 325-30. PMID 7698172 DOI: 10.1016/0014-2999(94)90669-6  0.92
1993 Pehek EA, Meltzer HY, Yamamoto BK. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. European Journal of Pharmacology. 240: 107-9. PMID 8405119 DOI: 10.1016/0014-2999(93)90555-V  0.92
1992 Pehek EA, Crock R, Yamamoto BK. Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions. Synapse (New York, N.Y.). 10: 317-25. PMID 1374937 DOI: 10.1002/Syn.890100406  0.92
1990 Pehek EA, Schechter MD, Yamamoto BK. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology. 29: 1171-6. PMID 2293059 DOI: 10.1016/0028-3908(90)90041-O  0.92
1990 Yamamoto BK, Pehek EA. A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Research. 506: 236-42. PMID 2137360 DOI: 10.1016/0006-8993(90)91256-G  0.92
1985 Freed CR, Yamamoto BK. Regional brain dopamine metabolism: A marker for the speed, direction, and posture of moving animals Science. 229: 62-65. PMID 4012312 DOI: 10.1126/Science.4012312  0.92
1984 Yamamoto BK, Freed CR. Reversal of amphetamine-induced circling preference in trained circling rats Life Sciences. 34: 675-682. PMID 6538253 DOI: 10.1016/0024-3205(84)90232-7  0.92
1984 Yamamoto BK, Freed CR. Asymmetric dopamine and serotonin metabolism in nigrostriatal and limbic structures of the trained circling rat Brain Research. 297: 115-119. PMID 6202362 DOI: 10.1016/0006-8993(84)90547-X  0.92
1984 Morgan ME, Yamamoto BK, Freed CR. Unilateral activation of caudate tyrosine hydroxylase during voluntary circling behavior. Journal of Neurochemistry. 43: 737-41. PMID 6146659 DOI: 10.1111/J.1471-4159.1984.Tb12794.X  0.92
1982 Yamamoto BK, Lane RF, Freed CR. Normal rats trained to circle show asymmetric caudate dopamine release. Life Sciences. 30: 2155-62. PMID 7109843 DOI: 10.1016/0024-3205(82)90289-2  0.92
1982 Yamamoto BK, Freed CR. The trained circling rat: A model for inducing unilateral caudate dopamine metabolism Nature. 298: 467-468. PMID 7088191 DOI: 10.1038/298467A0  0.92
Show low-probability matches.